This is a posting of my reply to British health economist Dr. Buchanan's Comment of February 17, 2018.  The original posts are: Medicines's future? The health economics of population-wide genomic screening (October 26, 2017) Cost-Effectiveness: From Genes to Healthcare System Reform (December 17, 2017) 2 thoughts on “Cost-Effectiveness: From Genes to Healthcare System Reform” (Reply, February … Continue reading Genes, Cost-Effectiveness and Healthcare Reform – Dialog with Dr. Buchanan →